Medicalchain.com Limited - Filleted accounts

Medicalchain.com Limited - Filleted accounts


Registered number
10840710
Medicalchain.com Limited
Filleted Accounts
30 June 2020
Medicalchain.com Limited
Registered number: 10840710
Balance Sheet
as at 30 June 2020
Notes 2020 2019
£ £
Fixed assets
Intangible assets 3 1,291,326 593,387
Tangible assets 4 13,862 14,189
Investments 5 1,332,627 1,080,000
2,637,815 1,687,576
Current assets
Debtors 6 251,754 353,752
Cash at bank and in hand 193,774 1,007,296
445,528 1,361,048
Creditors: amounts falling due within one year 7 (5,226,542) (4,775,056)
Net current liabilities (4,781,014) (3,414,008)
Net liabilities (2,143,199) (1,726,432)
Capital and reserves
Called up share capital 1,332 1,332
Profit and loss account (2,144,531) (1,727,764)
Shareholders' funds (2,143,199) (1,726,432)
The directors are satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The members have not required the company to obtain an audit in accordance with section 476 of the Act.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
Mr Mohammed Tayeb
Director
Approved by the board on 13 October 2021
Medicalchain.com Limited
Notes to the Accounts
for the year ended 30 June 2020
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover, if any includes revenue earned from the sale of goods and from the rendering of services. Turnover, if any from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover, if any from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Intangible fixed assets
Intangible assets include purchased computer software, capitalised website costs and software licences. The identifiable and directly associated external and internal costs of acquiring and developing software are capitalised and recognised as an intangible asset where the software is controlled by the Company, and where it is probable that future economic benefits will flow from its use over more than one year. Costs associated with maintaining software are recognised as an expense as incurred.

Computer software and other intangible assets are stated at cost less amortisation and impairment losses, if any.

Capitalised software costs and other intangible assets are amortised on a straight-line basis. The amortisation rates used for each class of intangible assets are:

Computer software - 0%
Website - 25% at reducing balance method
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Office equipment 20% straight line method.
Computer Equipment 33.33% straight line method.
Leasehold improvements 20% straight line method.
Investments
Investments in subsidiaries, associates and joint ventures are measured at cost less any accumulated impairment losses. Listed investments are measured at fair value. Unlisted investments are measured at fair value unless the value cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses. Changes in fair value are included in the profit and loss account.
Going Concern
The directors believe that the Company is experiencing sufficient development and that it is well placed to manage its business risks successfully. Accordingly, they have reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future and thus have opted to apply the going concern basis of accounting in preparing the financial statements.
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Taxation
A current tax liability is recognised for the tax payable on the taxable profit of the current and past periods. A current tax asset is recognised in respect of a tax loss that can be carried back to recover tax paid in a previous period. Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Provisions
Provisions (ie liabilities of uncertain timing or amount) are recognised when there is an obligation at the reporting date as a result of a past event, it is probable that economic benefit will be transferred to settle the obligation and the amount of the obligation can be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Leased assets
A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to ownership. All other leases are classified as operating leases. The rights of use and obligations under finance leases are initially recognised as assets and liabilities at amounts equal to the fair value of the leased assets or, if lower, the present value of the minimum lease payments. Minimum lease payments are apportioned between the finance charge and the reduction in the outstanding liability using the effective interest rate method. The finance charge is allocated to each period during the lease so as to produce a constant periodic rate of interest on the remaining balance of the liability. Leased assets are depreciated in accordance with the company's policy for tangible fixed assets. If there is no reasonable certainty that ownership will be obtained at the end of the lease term, the asset is depreciated over the lower of the lease term and its useful life. Operating lease payments are recognised as an expense on a straight line basis over the lease term.
Impairment of non-financial asset
At the end of each reporting period, the Company assesses whether there is any indication that an asset may be impaired. The assessment will include the consideration of external and internal sources of information. If such an indication exists, an impairment test is carried out on the asset by comparing the recoverable amount of the asset, being the higher of the asset's fair value less costs to sell and value in use to the asset's carrying value. Value in use is calculated by discounting the estimated future cash flows of the asset at a pre-tax discount rate reflected the specific risks in the asset. Any excess of the asset's carrying value over its recoverable amount is expensed to the Income statement.
Impairment testing is performed annually for intangible assets and indefinite lives. Assets that have an allocated impairment loss are reviewed for reversal indicators at the end of each reporting period. After recognition of an impairment loss, the amortisation charge for the asset is adjusted in future periods to allocate the asset's revised carrying amount on a systematic basis over its remaining useful life.

Impairment losses are recognised as an expense immediately.
Pensions
Contributions to defined contribution plans are expensed in the period to which they relate.
2 Employees 2020 2019
Number Number
Average number of persons employed by the company 12 19
3 Intangible fixed assets £
WIP & Website:
Cost
At 1 July 2019 612,533
Additions 707,950
At 30 June 2020 1,320,483
Amortisation
At 1 July 2019 19,146
Provided during the year 10,011
At 30 June 2020 29,157
Net book value
At 30 June 2020 1,291,326
At 30 June 2019 593,387
Employee/director salaries totalling £366,929 (£360,291:2019) related to software development was capitalised as work in progress during the period. The £612,533 brought forward balance was made up of £572,486 in WIP of development cost and £40,047 in website costs. The website cost only was amortised at 25%
4 Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 July 2019 17,889
Additions 3,251
At 30 June 2020 21,140
Depreciation
At 1 July 2019 3,700
Charge for the year 3,578
At 30 June 2020 7,278
Net book value
At 30 June 2020 13,862
At 30 June 2019 14,189
5 Investments
Other
investments
£
Cost
At 1 July 2019 1,080,000
Additions 252,627
At 30 June 2020 1,332,627
Historical cost
At 1 July 2019 1,080,000
At 30 June 2020 1,332,627
6 Debtors 2020 2019
£ £
Trade debtors 194,922 42,018
Other debtors 56,832 311,734
251,754 353,752
7 Creditors: amounts falling due within one year 2020 2019
£ £
Holiday Leave provision (see note 8) 16,570 13,682
Trade creditors - 2,090
Due to related parties 5,115,507 4,733,935
Taxation and social security costs 94,465 25,349
5,226,542 4,775,056
8 Annual Leave provision 2020 2019
£ £
At 1 July 2019 13,682 -
Utilised during the year (13,682) -
Additional provisions 16,569 -
At 30 June 2020 16,569 -
8 Loans to directors
Description and conditions B/fwd Paid Repaid C/fwd
£ £ £ £
Dr Abdullah Albeyatti (appointed 28 June 2017)
[Loan 1] - 61,636 (61,636) -
Mr Bara Mustafa (appointed 28 June 2017)
[Loan 1] - 61,636 (61,636) -
Mr Mohammed Tayeb (appointed 28 June 2017)
[Loan 1] - 123,272 (123,272) -
- 246,544 (246,544) -
9 Related party transactions
FRS 102 (paragraph 33.1A) exempts the reporting of transactions between group companies provided that any subsidiary which is party to the transaction is wholly owned by such a member. The Company has taken advantage of this exemption.

During the previous year, the company employees were provided £10,680.77 worth in tokens which were repaid on 05 July 2019.

During the previous year, the company loaned a total sum of £245,554.60 to the directors, which attracted an interest at 3%. The loan was repaid in full on 27/03/2020.

During the previous year, the company also provided an interest free loan of £55,500 to a company which is controlled by one of the directors of the company. The loan remain outstanding as at 30 June 2020

As at 30 June 2020, the company owed £5,115,507.23 (£4,733,935.11: 2019) to the related parties on which interest is accrued at 1.75% and the loan is repayable on demand.
10 Controlling party
Mr Mohammed Tayeb is the ultimate controlling party of the company by virtue of his shareholdings in the company.
11 Other information
Medicalchain.com Limited is a private company limited by shares and incorporated in England. Its registered office is:
113 Shoreditch High Street
London
E1 6JN
Medicalchain.com Limited 10840710 false 2019-07-01 2020-06-30 2020-06-30 VT Final Accounts April 2021 Mr Mohammed Tayeb No description of principal activity 10840710 2018-07-01 2019-06-30 10840710 core:WithinOneYear 2019-06-30 10840710 core:ShareCapital 2019-06-30 10840710 core:RetainedEarningsAccumulatedLosses 2019-06-30 10840710 2019-07-01 2020-06-30 10840710 bus:PrivateLimitedCompanyLtd 2019-07-01 2020-06-30 10840710 bus:AuditExemptWithAccountantsReport 2019-07-01 2020-06-30 10840710 bus:Director40 2019-07-01 2020-06-30 10840710 1 2019-07-01 2020-06-30 10840710 2 2019-07-01 2020-06-30 10840710 core:Goodwill 2019-07-01 2020-06-30 10840710 core:PlantMachinery 2019-07-01 2020-06-30 10840710 bus:Director1 2019-07-01 2020-06-30 10840710 bus:Director1 1 2019-07-01 2020-06-30 10840710 bus:Director2 2019-07-01 2020-06-30 10840710 bus:Director2 1 2019-07-01 2020-06-30 10840710 bus:Director3 2019-07-01 2020-06-30 10840710 bus:Director3 1 2019-07-01 2020-06-30 10840710 countries:England 2019-07-01 2020-06-30 10840710 bus:FRS102 2019-07-01 2020-06-30 10840710 bus:FullAccounts 2019-07-01 2020-06-30 10840710 2020-06-30 10840710 core:WithinOneYear 2020-06-30 10840710 core:ShareCapital 2020-06-30 10840710 core:RetainedEarningsAccumulatedLosses 2020-06-30 10840710 core:Goodwill 2020-06-30 10840710 core:PlantMachinery 2020-06-30 10840710 core:AdditionsToInvestments 2020-06-30 10840710 bus:Director1 1 2020-06-30 10840710 bus:Director2 1 2020-06-30 10840710 bus:Director3 1 2020-06-30 10840710 2019-06-30 10840710 core:Goodwill 2019-06-30 10840710 core:PlantMachinery 2019-06-30 10840710 bus:Director1 1 2019-06-30 10840710 bus:Director2 1 2019-06-30 10840710 bus:Director3 1 2019-06-30 iso4217:GBP xbrli:pure